Leprosy at the Cutting Edge: 2000 to 2005,and Beyond

World Health Organization. The Elimination of Leprosy as a Public Health Problem: Status Report 2000. Geneva: WHO, 2000 [http://www.who.int/lcp/].

World Health Organization. Chemotherapy of Leprosy for Control Programmes. WHO Technical Report Series, No. 675. Geneva: WHO, 1982.

World Health Organization. WHO Expert Committee on Leprosy, WHO Technical Report Series, No. 874. Geneva: WHO, 1998.

World Health Organization. Leprosy — global situation. Wkly Epidemiol Rec 2000;75:226–31.

World Health Organization. The Final Push Towards Elimination of Leprosy: Strategic Plan 2000–2005. Geneva: WHO, 2000.

Smith WCS . We need to know what is happening to the incidence of leprosy. Lepr Rev 1997;68:195–200.

World Health Organization. Report on the First Meeting of the WHO Technical Advisory Group on Elimination of Leprosy, Geneva 2–3rd May, 2000. Geneva: WHO, 2000.

Neira MP . Remaining challenges towards elimination of leprosy. Lepr Rev 2000;71:422–65.

Nicholls PG . Guidelines for social and economic rehabilitation. Lepr Rev 2000;71:422–65 (Copies are available free of charge from ILEP, 234 Blythe Road, London W14 0HJ, UK).

Brosch R Gordon SV Eiglmeier K Garnier T Cole ST . Comparative genomics of the leprosy and tubercle bacilli. Res Microbiol 2000;151:135–42.

Curtiss R Blower S Cooper K Russell D Silverstein Young L . Leprosy research in the post-genome era. Lepr Rev 2001;72:8–22.

MILEP2 Study Group. Approaches to study the transmission of Mycobacterium leprae. Lepr Rev 2000;71:S26–29.

Smith CM Smith WCS . Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect 2000;41:137–42.

Croft RP Nicholls PG Steyerberg EW Richardus JH Smith WCS . A clinical prediction rule for nerve function impairment in leprosy patients. Lancet 2000;355:1603–6.

Smith WCS . Review of current research in the prevention of nerve damage in leprosy. Lepr Rev 2000;71:S138–45.